Induction of genotoxic damage and ROS production in HCT116 TP53+/+ and HCT116 TP53−/− colorectal cancer cell lines by anticancer drugs

Mutagenesis · Published 2026-03-22 · DOI 10.1093/mutage/geag014

Authors being retrieved — see the publisher record. https://doi.org/10.1093/mutage/geag014

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Related articles

• DNA damage in oral mucosal epithelial cells cultured in complex and xenobiotic-free media: a comparison study · Mutagenesis · 2025 · Same journal
• Understanding the cellular uptake and genotoxic potential of industrial relevant nanomaterials utilizing electron microscopy and the ToxTracker assay in vitro · Mutagenesis · 2025 · Same journal
• Industrial genotoxicology group: 38th annual meeting report · Mutagenesis · 2026 · Same journal
• Ultra-processed foods and diet quality in long COVID: associations with symptom burden, DNA damage, and inflammation · Mutagenesis · 2026 · Same journal
• Industrial Genotoxicology Group: 36th Annual Meeting Report · Mutagenesis · 2024 · Same journal
• Determination of global DNA methylation level by methylation-sensitive comet assay in patients with urinary bladder cancer · Mutagenesis · 2024 · Same journal
• Nutritional maternal factors affect the frequency of DNA damage in newborns · Mutagenesis · 2026 · Same journal
• Using error-corrected sequencing for evaluating mutagenicity of molnupiravir in humans · Mutagenesis · 2026 · Same journal
• The Buccal Micronucleus (BMN) Cytome assay: enhancing its applications by addressing challenges and exploring new opportunities · Mutagenesis · 2026 · Same journal
• Global DNA methylation and its association with genetic instability and exposure to inorganic elements and polycyclic aromatic hydrocarbons in coal mining dust · Mutagenesis · 2025 · Same journal